Logo
Home
Company ProfileBoards & StaffsMemberships & PartnersAcademy of JournalismCareersBlog(EN)Contact Us
Our JournalsInstruction for AuthorsBrieflands PoliciesPublish My ResearchJournal Management SystemArticle Processing ChargesOpen Peer ReviewPublishing Services
Publish My Book
  1. Brieflands
  2. journals
  3. Archives of Clinical Infectious Diseases
  4. Articles

  5. Acute Kidney Injury After Nephrotoxic Antibiotic Therapy in Patients with Infective Endocarditis
  6. Scopus by Title (Ref)

Archives of Clinical Infectious Diseases

Infectious Diseases and Tropical Medicine Research Center, SBUMS

Home
Current IssueAccepted ManuscriptsAll IssuesIn PressSearch
Instructions
Journal InformationEditors & BoardsIndexing and Listing SourcesJournal MetricsPublication Ethics and Malpractice StatementSupportContact UsReviewer and AE Registration FormOpen Peer Review (OPR)
APC
Authors GuideSubmit Manuscript

Scopus by Title (Ref)


1. Synthetic Data–Driven Early Prediction Framework for Acute Kidney Injury in Patients Receiving Vancomycin and Ceftazidime/Avibactam

- Ramazani M. , et al.

2. The interplay of TapSAKI and NEAT-1 as potential modulators in gentamicin-induced acute kidney injury via orchestrating miR-22-3p/TLR4/MyD88/NF-қB/IL-1 β milieu: Novel therapeutic approach of Betanin

- Abd-Elmawla M.A. , et al.

3. Outcomes of Acute Kidney Injury among Hospitalized Patients with Infective Endocarditis: A National Inpatient Sample Analysis

- Chandramohan D. , et al.

4. Infective Endocarditis

- Alizadehasl A. , et al.

HomeInstructionsAPC

Articles

  • Current Issue
  • Accepted Manuscripts
  • All Issues
  • In Press
  • Search

About Journal

  • Journal Information
  • Editors & Boards
  • Indexing and Listing Sources
  • Journal Metrics
  • Publication Ethics and Malpractice Statement
  • Support
  • Contact Us
  • Reviewer and AE Registration Form
  • Open Peer Review (OPR)
Support
Submit a Ticket
BrieflandsBrieflands

Science, Technical, Medical Publisher, Since 2007

All rights reserved by Brieflands, 2026.

Powered by Neoscriber.